Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Dr. Sherman

Pharmaceutical Sciences
Horizon Pharmaceuticals


Dr. Sherman joined Horizon Pharma in June 2009 as executive vice president, development and regulatory affairs and chief medical officer. From June 2011 to Sept. 2014, he served as executive vice president, development, manufacturing, and regulatory affairs and chief medical officer. Since then, he has served as executive vice president, research and development and chief medical officer. From June 2009 to June 2010, Dr. Sherman also served as president and board member of the Drug Information Association (DIA), a nonprofit professional association of members who work in government regulatory, academia, patient advocacy and the pharmaceutical and medical device industry. Dr. Sherman serves as DIA liaison to the Clinical Trial Transformation Initiative (CTTI), a public-private partnership founded by the U.S. Food and Drug Administration and Duke University to improve the quality and efficiency of clinical trials. He also serves on the board of advisors of the Center for Information and Study on Clinical Research Participation (CISCRP) a nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media and policy makers about clinical research and the role each party plays in the process. He is an adjunct assistant professor of medicine at the Northwestern University Feinberg School of Medicine and is a member of a number of professional societies, as well as a diplomat of the National Board of Medical Examiners and the American Board of Internal Medicine. From August 2007 to June 2009, Dr. Sherman served as senior vice president of research and development and chief medical officer at IDM Pharma, which was acquired by Takeda in 2009. From June 2007 to Aug. 2007, he served as vice president of clinical science at Takeda Global Research and Development. From Sept. 2000 through June 2007, Dr. Sherman served as chief medical officer and executive vice president at NeoPharm, Inc., a biopharmaceutical company. From October 1992 to Aug. 2000, Dr. Sherman served as director, senior director and executive director of clinical research, and was head of oncology global medical operations at Searle/Pharmacia, or Searle. Dr. Sherman received his medical degree from the Rosalind Franklin University/Chicago Medical School. He completed an internal medicine internship, residency and chief medical residency at Northwestern University, as well as fellowship training at the University of California, San Francisco (UCSF). Dr. Sherman was also a research associate at the Howard Hughes Medical Institute at UCSF.

Research Interest

global cardiovascular

Global Experts from Ireland

Global Experts in Subject

Share This Profile